Breaking Down Barriers to Drug Delivery
Defence Therapeutics is a preclinical-stage biopharma company specializing in next-generation intracellular drug delivery to enhance the potency and safety of cancer therapies, including antibody-drug conjugates (ADCs).
About Us
We are committed to safer and more powerful cancer therapies
Accum Platform
Escaping traditional barriers to enable next-generation therapeutics
Investors
Continuing to advance our cause